Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating) Director Noah G. Levy bought 20,938 shares of the company’s stock in a transaction dated Tuesday, June 14th. The stock was purchased at an average cost of $5.17 per share, for a total transaction of $108,249.46. Following the completion of the acquisition, the director now owns 1,010,515 shares […]